Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis

Anticancer Research

Volumn 26, Issue 3 B, 2006, Pages 2221-2226

  Rino, Yasushi ^a   Tarao, Kazuo ^b   Morinaga, Souichiro ^a   Ohkawa, Shinichi ^b   Miyakawa, Kaoru ^b   Hirokawa, Satoru ^b   Masaki, Takahiro ^b   Tarao, Norio ^c   Yukawa, Norio ^a   Saeki, Hiroyuki ^a   Takanashi, Yoshinori ^a   Imada, Toshio ^d  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c SEIREI CHRISTOPHER UNIVERSITY   (Japan)

^d YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Alanine aminotransferase; HCC; Hepatitis C virus associated liver cirrhosis; Hepatocarcinogenesis; Prevention

Indexed keywords

GLYCYRRHIZIC ACID; NEOMINOPHAGEN C; PROTOPORPHYRIN; SHI QUAN DA BU TANG; URSODEOXYCHOLIC ACID; XIAO CHAI HU TANG;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; DRUGS, CHINESE HERBAL; FEMALE; GLYCYRRHIZIC ACID; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTOPORPHYRINS; RETROSPECTIVE STUDIES; URSODEOXYCHOLIC ACID;

EID: 33745530953     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lavanchy D: Hepatitis C. 170 Million Infected Worldwide and Still No Vaccine [press release no. 36]. World Health Organization May 1, 1998.
2. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y and Kobayashi K: Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 12: 680-687, 1990.
3. Ikeda K, Saito S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H and Kawanishi M: A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18: 47-53, 1993.
4. Kaneko S, Unoura M, Takeuchi M, Terasaki S, Ogino H, Matsushita E and Kobayashi K: The role of hepatitis C virus in hepatocellular carcinoma in Japan. Intervirology 37:108-113, 1994.
5. Tarao K, Rino Y, Ohkawa S, Shimizu A, Tamai S, Miyakawa K, Aoki H, Imada T, Shindo K, Okamoto N and Totsuka S: Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 86: 589-595, 1999.
6. Tarao K, Rino Y, Takemiya S, Tamai S, Ohkawa S, Sugimasa Y, Miyakawa K, Morinaga S, Yoshida M, Shibuya A, Kokubu S, Kakita A and Endo O: Close association between high serum ALT and more rapid recurrence of hepatocellular carcinoma in hepatectomized patients with HCV-associated liver cirrhosis and hepatocellular carcinoma. Intervirology 43: 20-26, 2000.
7. Tarao K, Rino Y, Ohkawa S, Tamai S, Miyakawa K, Takakura H, Endo O, Yoshitsugu M, Watanabe N and Matsuzaki S: Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis. Cancer 94: 1787-1795, 2002.
8. Tarao K, Rino Y, Takemiya S, Ohkawa S, Sugimasa Y, Miyakawa K, Tamai S, Masaki T, Hirokawa S, Kameda Y, Nagaoka T, Okamoto N, Kokubu S, Yoshida M and Kakita A: Serum alanine aminotransferase levels and survival after hepatectomy in patients with hepatocellular carcinoma and hepatitis C virus-associated liver cirrhosis. Cancer Sci 94:1083-1090, 2003.
9. Tarao K, Rino Y, Ohkawa S, Endo O, Miyakawa K, Tamai S, Hirokawa S, Masaki T, Nagaoka T, Okamoto N, Tanaka K and Tarao N: Sustained low alanine aminotransferase levels can predict the survival for 10 years without hepatocellular carcinoma development in patients with hepatitis C virus-associated liver cirrhosis of Child stage A. Intervirology 47: 65-71, 2004.
10. Child CG III and Turcotte JG: Surgery and portal hypertension. In: The Liver and Portal Hypertension. Dunphy JE (ed.). Philadelphia. W.B. Saunders, vol. 50, 1964.
11. Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawara S, Momosaki S and Kojiro M: The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res 54: 448-454, 1994.
12. Suzuki H, Ohta Y, Takino T, Fujisawa K and Hirayama C: Effects of glycyrrhizin on biochemical tests in patiens with chronic hepatitis - double blind trial. Asian Med J 26: 423438, 1983.
13. Hirayama C, Okumura M, Tanikawa K, Yano M, Mizuta M and Ogawa N: A multicenter randmaized control clinical trial of Sho-saiko-to in chronic active hepatitis. Gastroenterol Jpn 24: 715-719, 1989.
14. Bellentani S, Podda M, Tiribelli C, Callea F, Marazzi M, Sodde M, Merlini R, Batezzati PM, Crosignani A and Zuin M: Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial. J Hepatol 19: 459-464, 1993.
15. Tarao K, Tamai S, Ohkawa S, Miyakawa K, Aoki H, Takashimizu S, Kagawa T, Watanabe N and Matsuzaki S: The effects of combined drug therapy on the serum alanine aminotransferase levels in HCV-associated liver cirrhosis. Rinsho-to-Kenkyu 75: 1858-1867, 1998 (in Japanese).
16. Zelman S and Wang CC: Transaminases in serum and liver correlated with liver cell necrosis in needle aspiration biopsies. Am J Med Sci 237: 323-334, 1959.
17. Schmidt E, Schmidt FW and Wildhirt E: Activitäts-Bestimmungen von enzymen des energieliefernden Stoffwechsels in menschlichen serum und in leberpunktaten bei leberkrankungen. Hin Wschr 36: 280-287, 1958.
18. Baier H, Hennemann G and Mühler E: Beitrag zur aktivitä tsbeurteilung chronischer Leberekrankungen druch bestimmung von serumenzymen. Klin Wschr 39:117-119, 1961.
19. Gratzner HG: Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218: 474-476, 1982.
20. Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Ito Y, Tamai S, Hoshino H, Inoue T and Kanisawa M: Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients. Cancer 73: 1149-1154, 1994.
21. Tarao K, Shimizu A, Ohkawa S and Tamai S: Prediction of the development of hepatocellular carcinoma from HCV associated liver cirrhosis. J Jap Soc Int Med 84: 1985-1991, 1995 (in Japanese).
22. Slaga TJ and Scribner JD: Inhibition of tumor initiation and promotion by anti-inflammatory agents. J Natl Cancer Inst 57: 1723-1725, 1973.
23. Cameron R, Lee G and Farber E: Chemical mitogens as effective alternatives to partial hepatectomy in the new model for the sequential analysis of hepatocarcinogenesis. Proc Am Assoc Cancer Res 19: 56, 1978.
24. Marks F, Bertsch S, Grimm W and Schweizer J: Hyperplastic transformation and tumor promotion in mouse epidermis: possible consequences of disturbances of endogenous mechanism controlling proliferation and differentiation. In: Carcinogenesis. Slaga TJ, Sivak A, Boutwell RK (eds.). New York, Raven, vol. 2, pp. 97-116, 1978.
25. Argyris TS: Tumor promotion by damage-induced epidermal hyperplasia in the skin of mice. Proc Am Assoc Cancer Res 20: 4, 1979.
26. Tarao K, Shimizu A, Ohkawa S, Harada M, Ito Y, Tamai S, Kuni Y, Okamoto N, Inoue T and Kanisawa M: Development of hepatocellular carcinoma associated with increases in DNA synthesis in the surrounding cirrhosis. Gastroenterology 103: 595-600, 1992.
27. Tarao K, Hoshino H, Shimizu A, Ohkawa S, Nakamura Y, Harada M, Ito Y, Tamai S, Akaike M, Sugimasa Y, Takemiya S, Okamoto T and Okamoto N: Role of increased DNA synthesis activity of hepatocytes in multicentric hepatocarcinogenesis in residual liver of hepatectomized cirrhotic patients with hepatocellular carcinoma. Jpn J Cancer Res 85: 1040-1044, 1994.
28. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K and Tsuneyoshi M: Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 108: 768-775, 1995.
29. Tarao K, Takemiya S, Tamai S, Sugimasa Y, Ohkawa S, Akaike M, Tanabe H, Shimizu A, Yoshida M and Kakita A: Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associatied cirrhosis and HCC. Cancer 79: 688-694, 1997.